Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Oncology Reports|April 9, 2024
Current Systemic Therapy in Men with Metastatic Castration-Sensitive Prostate CancerGuillaume Grisay, Pernelle Lavaud, Karim Fizazi
Critical Reviews in Oncology/Hematology|January 22, 2022
Global management of brain metastasis from renal cell carcinomaJulien Pierrard, Thaïs Tison, Guillaume Grisay, et al.
Current Treatment Options in Oncology|December 3, 2020
Future Strategies Involving Immune Checkpoint Inhibitors in Advanced Urothelial CarcinomaGuillaume Grisay, Julien Pierrard, Caterina Confente, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Lung Toxicity Occurring During Enfortumab Vedotin Treatment: From a Priming Case Report to a Retrospective AnalysisGrégoire Desimpel, François Zammit, Sarah Lejeune, et al.
Biomaterials|March 20, 2013
Critical size bone defect reconstruction by an autologous 3D osteogenic-like tissue derived from differentiated adipose MSCsThomas Schubert, Sébastien Lafont, Gwen Beaurin, et al.
Clinical Genitourinary Cancer|July 20, 2026
Early Intermittent Cabozantinib in Metastatic Renal Cell Carcinoma: Efficacy and Safety in a Multicenter Retrospective AnalysisRaphaelle Dermine, Julie Harmant, Marco Gizzi, et al.
Frontiers in Oncology|May 23, 2024
EORTC 2238 "De-Escalate": a pragmatic trial to revisit intermittent androgen deprivation therapy in the era of new androgen receptor pathway inhibitorsGuillaume Grisay, Fabio Turco, Saskia Litiere, et al.
Targeted Oncology|February 6, 2020
c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer: From a Case Report to Patient Cohort AnalysisValentin Van den Bossche, Gaspard Jadot, Guillaume Grisay, et al.
European Urology|August 5, 2026
EORTC 2238 DE-ESCALATE: Revisiting Intermittent Maximal Androgen Blockade in Metastatic Hormone-sensitive Prostate CancerGuillaume Grisay, Fabio Turco, Anna Patrikidou, et al.
Current Oncology (Toronto, Ont.)|August 27, 2025
Systematic Literature Review on Economic Evaluations and Health Economic Models in Metastatic Castration-Sensitive Prostate CancerThanh Tu Nguyen, David Ameyaw, George Dennis Obeng, et al.
Pageof 2